Scientists develop method to examine HIV drugs' structure

01/31/2010 | Reuters

A team of U.S. and British researchers created a crystal to further examine the 3-D structure of HIV drugs from Merck & Co. and Gilead Sciences and how they bind to and inhibit the integrase enzyme. The crystal, which was grown from an integrase found in a retrovirus similar to HIV, could help improve HIV medicines and prevent drug resistance, according to the study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC